
KLOW
80mg
$100.00
KLOW combines GHK-Cu, BPC-157, TB-500 and KPV in a single vial. Each component appears separately in preclinical tissue-repair literature; the blend itself is a supplier formulation rather than a studied composition.
For laboratory research use only.
SKU ASC-KLOW
Product detail
Description
KLOW combines GHK-Cu, BPC-157, TB-500 and KPV in a single vial. Each component appears separately in preclinical tissue-repair literature; the blend itself is a supplier formulation rather than a studied composition.
For laboratory research use only.
Documentation
Two documents. Vanguard Laboratory V260831-53, released September 15, 2026, reports chromatographic purity, per-component quantities and endotoxin for lot 206076380. Janoshik Analytical task #211034 covers identity and amount for all four components across three vials of batch 2026076380, with peptide purity explicitly outside its scope. The two lot numbers differ by a single digit, and neither document establishes that they are the same lot.
Available reports for the whole catalog are published in the COA library.
Lot documentation
Each report below applies only to the sample, batch, and analyses named in that document. Reports are published as received. Where a report was supplied by the supplier rather than commissioned by ASCND Research, it is labelled as such.
KLOW 80mg — purity and endotoxin
Supplier-supplied report. Not commissioned by ASCND Research.
- Laboratory
- Vanguard Laboratory
- Reference
- Lab ID V260831-53 001
- Batch
- 206076380
- Reported purity
- >99.50%
- Reported content
- This report does not show a content result.
- Reported
- September 15, 2026
Scope of this report
Identity passed against a reference standard. This is the first purity and endotoxin figure published for KLOW; the content analysis beside it covers neither. Read the purity with the laboratory's own caveat, printed on the certificate: blend purity is the combined chromatographic area % of the peaks it identified as the intended components, not absolute mass purity, and it establishes neither individual component purity nor the ratio between them. Measured quantities are GHK-Cu 68.15 mg, BPC-157 15.17 mg, TB-500 12.68 mg and KPV 11.72 mg, which total 107.72 mg against the 80 mg the same certificate names as the amount. Endotoxin is 7.59 EU/mg — per milligram, not the per-vial figure other reports in this catalog print. One vial was tested. The lot number here, 206076380, is the content analysis's batch 2026076380 less one digit; nothing in either document establishes that the two are the same lot.
KLOW 80mg — content analysis
Supplier-supplied report. Not commissioned by ASCND Research.
- Laboratory
- Janoshik Analytical
- Reference
- Task #211034
- Batch
- 2026076380
- Reported purity
- Not tested
- Reported content
- This report does not show a content result.
- Reported
- July 29, 2026
Scope of this report
The report states its own limit in its title: identity and amount, PEPTIDE PURITY NOT INCLUDED. Three vials were measured and vary between them — KPV 14.33 / 11.64 / 13.22 mg, BPC-157 11.43 / 9.32 / 10.27 mg, TB-500 (TB4) 12.84 / 10.33 / 11.73 mg, and GHK-Cu 64.42 / 52.07 / 59.16 mg. This document carries no purity, microbial or endotoxin figure of its own; the Vanguard certificate for lot 206076380 reports purity and endotoxin, and those lot numbers differ by one digit. Verification key ZAVQRJYXWPHD.
Research-use notice
For laboratory and research use only. Not for human consumption, veterinary use, or medical application. Purchaser must be 21 years or older.

